Detail akcie McKesson online

Business Summary: McKesson Corporation is a provider of diversified healthcare services. It is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment includes its operations in Norway, which provides distribution and services to wholesale and retail customers.
Financial Summary: BRIEF: For the nine months ended 31 December 2024, McKesson Corp revenues increased 15% to $268.23B. Net income decreased 8% to $2.04B. Revenues reflect U.S. Pharmaceutical segment increase of 71% to $244.55B, International segment increase of 58% to $11.26B, Medical-Surgical Solutions segment increase of 45% to $8.53B. Net income was offset by International segment loss totaling $307M vs. income of $192M.